- Home
- CLLS vs RC Comparison
CLLS vs RC Comparison
Compare CLLS & RC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CLLS | RC |
|---|---|---|
| Founded | 1999 | 2007 |
| Country | France | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 438.4M | 424.8M |
| IPO Year | 2007 | N/A |
Fundamental Metrics
Financial Performance| Metric | CLLS | RC |
|---|---|---|
| Price | $3.54 | $2.05 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 2 | 4 |
| Target Price | ★ $8.50 | $2.94 |
| AVG Volume (30 Days) | 40.7K | ★ 2.8M |
| Earning Date | 03-12-2026 | 03-02-2026 |
| Dividend Yield | N/A | ★ 1.92% |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $82,551,000.00 | N/A |
| Revenue This Year | $32.58 | N/A |
| Revenue Next Year | $20.68 | $11.33 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 129.04 | N/A |
| 52 Week Low | $1.10 | $1.97 |
| 52 Week High | $5.48 | $7.03 |
Technical Indicators
Market Signals| Indicator | CLLS | RC |
|---|---|---|
| Relative Strength Index (RSI) | 32.21 | 38.21 |
| Support Level | $4.04 | $2.07 |
| Resistance Level | $3.95 | $2.33 |
| Average True Range (ATR) | 0.21 | 0.12 |
| MACD | -0.06 | -0.01 |
| Stochastic Oscillator | 0.00 | 10.87 |
Price Performance
Historical ComparisonAbout CLLS Cellectis S.A.
Cellectis SA is a clinical stage biotechnological company, employing the core proprietary technologies to develop products based on gene-editing, with a portfolio of allogeneic Chimeric Antigen Receptor T-cells, or UCART, product candidates in the field of immuno-oncology and gene-edited hematopoietic stem and progenitor cells, or HSPC product candidates in other therapeutic indications.
About RC Ready Capital Corproation
Ready Capital Corp is a real estate finance company. It acquires, manages, originates, and finances small-balance commercial loans to purchase small multi-family, office, retail, mixed-use, or warehouse properties. The company's segments consist of LMM Commercial Real Estate and Small Business Lending. It generates the majority of its revenue from LMM Commercial Real Estate.